María-Carlota Londoño

24PUBLICATIONS
122CO-AUTHORS
Gastroenterology and hepatologyClinical pharmacy and pharmacy practiceGlycoconjugatesToxicology (incl. clinical toxicology)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 06, 2026
Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes.

|May 04, 2026
Editorial: UDCA Dosing in PBC - Between Guideline Adherence and Clinical Reality.

|Nov 19, 2025
Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study.

Christopher L Bowlus, Douglas Thorburn, Stephen T Barclay

|Jun 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.

Cynthia Levy, Palak J Trivedi, Kris V Kowdley

|May 29, 2024
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.

Mar Riveiro-Barciela, Ana Barreira-Díaz, Paula Esteban

|Dec 22, 2023
Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.

Anna Pocurull, Maria José Moreta, David Heitman

Pageof 4

Frequent Collaborators

6 joint publications

Sabela Lens

6 joint publications

Sergio Rodríguez-Tajes

6 joint publications

Xavier Forns

5 joint publications

Zoe Mariño